Radiation Safety:
Mention should also be made here about the issue of radiation safety since
there are often concerns about whether men are radioactive following an
implant and pose a possible danger to those around them. This is not the
case. As mentioned earlier, seeds emit low-energy radiation that is
absorbed by tissue within a very short distance from seed. In addition,
the seeds lose some of their energy every day due to the relatively short
half-life of the radioactive materials used in their manufacture
(Iodine125 or Palladium103). For these reasons, most of the radiation from
the implant will remain confined to the prostate itself. Nevertheless, it
is possible that a small amount of radiation will be found at the surface
of the skin at the lower abdomen. Patients, therefore, are urged to follow
a few simple precautions in the period immediately following the implant.
These include avoiding prolonged, close contact with children under 2
years of age and with pregnant women during the first month or two
following treatment
Long-Term
Complications: An attractive feature of seed implants is the low incidence of long-term complications that can have a serious impact on a man’s quality of life and self esteem. Impotence, incontinence, and rectal injury are the primary
concerns of men and their families. These risks are common to all forms of prostate cancer treatment, but there is a general sense that they are less likely to occur with seed implantation.
The probability and severity of any complications will vary from one patient to another and an experienced physician will be able to assess these risks for the individual.
Impotence: According to the American Cancer Society, the loss of sexual function following seed implantation is less than with other forms of treatment. The ACS estimates that, depending on age, 10-30% of men will become impotent as a result of seed implantation compared to 40-60% with external beam radiation and 65-90% with the standard radical surgery. With the “nerve sparing” prostatectomy, the ACS reports impotency rates of 25-30% for men under 60 and 70% for those over 70. At the Seattle Prostate Institute, our experience largely mirrors the ACS findings as illustrated in the following table.